This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 10, 2013

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Do you have a company or organization that has initiated a highly innovative program focused on preventative measures and lifestyle changes? Nominate them for the NAMCP Prevention and Lifestyle Change Innovation Award. Please Click here to download the application for more information.

Please click here to view Eisai's 2012 Oncology Digest. The PDF contains two articles and the final oncology digest.

Please click here to view the webcast on Eisai's 2012 Oncology Digest from the Fall Managed Care Forum.

Save the Date!
Spring Managed Care Forum
May 2-3, 2013
Gaylord Palms
Orlando, Fla.

The NAMCP Behavioral Health Institute (BHI) is pleased to recognize the WVP Health Authority as the 2012 Behavioral Health Innovation Award winner.

Click here for the press release!

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts

Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.



Scientists link gene variant to human longevity    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Their findings, published in the Journal of Neuroscience, show that the genetic variant called the dopamine receptor 4 7-repeat allele, or DRD4 7R allele for short, appears in significantly higher rates in people more than 90-years old. DRD4 7R allele is part of the dopamine system, which facilitates the transmission of signals among neurons and plays a major role in the brain network responsible for attention and reward-driven learning. More

What mice can tell us about obesity and genetics
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
While our eating habits certainly play a role in how much we weigh, our rodent cousins confirm that some of our risk for obesity is written in our genes. For over two years, the researchers at the University of California, Los Angeles, studied the effect of high-fat and high-sugar diets on more than 100 genetic strains of laboratory mice. More

Genetics link epilepsy and migraines
Everyday Health    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Columbia University have discovered the missing genetic link between migraines and epilepsy — a finding that they say explains why individuals suffer from both diseases relatively often — and that may one day lead to improved diagnosis and treatment. More

Call for contributors
MultiBriefs    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In an effort to enhance the overall content of GBEMTI eNews, we'd like to include peer-written articles in future editions. As a member of GBEMTI, your knowledge of the industry lends itself to unprecedented expertise. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit and our group of talented editors can help with final edits. If you're interested in participating, please contact Colby Horton to discuss logistics and payment. More

Genetics discovery to help fight 'black fever'
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Leishmaniasis affects 12 million people and there are an estimated 1.5 million new cases annually, mainly in India, Bangladesh, Nepal, Sudan, South Sudan, Ethiopia and Brazil. Visceral leishmaniasis, also known as black fever, is the second-largest parasitic killer in the world after malaria. More

 Biotech/Diagnostics/Personalized Medicine

Study: DNA mutations can help personalize medicine
PolicyMic    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As humans, we like to think our genes are of a superior caliber and rarely mutate — especially if we are fit and healthy. Despite this, new research reveals that natural genetic mutations are more frequent than originally thought, which can provide further insight into the mechanisms that are necessary for adaptation to the environment. More

Earn your MS in Nursing Online

Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people. MORE

 Regenerative Medicine

Safety of induced stem cells gets a boost
Nature    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A paper published in Nature could dispel a cloud over the hopes of turning a patient's own cells into perfectly matched replacement tissues. Scientists first reported in 2007 that a person's cells could be reprogrammed to an embryo-like state, and so could form any type of cell in the body. Medical researchers immediately imagined using these "induced pluripotent stem cells" to create an endless supply of genetically matched replacement tissues to treat a range of diseases: Fresh pancreatic tissue for diabetics, for example, or new nerve cells for people with Parkinson's. More

Stem cell materials could boost research into key diseases
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stem cell manufacturing for drug screening and treatments for diseases such as Huntington's and Parkinson's could be boosted by a new method of generating stem cells, a study suggests. Scientists have developed a family of compounds that can support the growth of human embryonic stem cells on a large scale for use in drug testing or treatments. More

 Emerging Medical Technologies

Cliff deal cuts imaging reimbursement, leaves medical device excise tax intact
Bloomberg BNA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Representatives of the medical devices industry expressed disappointment that the White House deal with Congress to avert the so-called fiscal cliff did not address the medical device tax, which took effect Jan. 1. Medical imaging technology stakeholders also said they were disappointed with Medicare cuts for imaging and radiation therapy services that were included in the bill as a way to provide relief to physicians who were facing a big cut in pay. More

FDA OKs Georgia companies' medical devices
Atlanta Business Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A number of new medical devices made by Georgia companies, including a blood test tool and laser tool, have been green lighted by the Food and Drug Administration. The FDA made public new medical devices it approved in December. One of these is a blood diagnostic tool made by Sebia of Duluth, Ga. More

Discover the Concentra Difference.

Concentra offers medical practice expertise, operational and peer support, and long-term stability to enable your professional and financial success. Our providers work consistent schedules that encourage healthy work-life balance, and experience the satisfaction of working in an environment designed to reduce administrative burden while allowing more time for patient care.

Stomach-pumping machine makes calories disappear
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A group of inventors, who include the creator of the Segway, has come up with a gadget that lets people eat pretty much what they want and forget about the calories. Sound too good to be true? Called the AspireAssist device, it works by sucking the food right out of the stomach so that only about a third of the calories are absorbed by the body. More

 Managed Healthcare News

Health insurance to rise 20 percent or more in California
NBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefSeveral states including California, Florida and Ohio are facing double-digit health insurance rate increases. California insurance commissioner deemed one proposed group insurance increase unreasonable and accused companies of trying to maximize profits. NBC's Lisa Myers reports. More

Flu hitting US fast as insurers brace for claims
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. influenza season is off to a fast start, which may hurt insurers, hospitals and people lulled by the milder outbreaks of the recent past. The U.S. has seen elevated levels of the flu for the past month, said Michael Jhung, a medical officer with the U.S. Centers for Disease Control and Prevention's influenza unit. About 5.6 percent of all doctor visits in the U.S. now are for influenza, according to the Atlanta-based agency. More

 FDA: New Treatments and Technology

US FDA announces first Breakthrough Therapy Designations
PharmaTimes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The U.S. Food and Drug Administration's first Breakthrough Therapy Designations have been granted to two cystic fibrosis treatments from Vertex Pharmaceuticals. One designation is awarded to Vertex' Kalydeco monotherapy, for potential additional indications beyond the drug's currently-approved use in CP patients aged six and over who have the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene; there are estimated to be around 2,000 such patients worldwide. More

Why does FDA keep drugmakers from informing doctors?
Investor's Business Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Every day, millions of Americans benefit from drugs their physicians prescribed for uses and indications beyond those listed on the drug's FDA-approved label. Some of these off-label uses include treatment for diseases or symptoms, or patient population, not formally reviewed by the Food and Drug Administration. Off-label drug prescribing has been a boon to public health and continues to grow. A 2006 study in the Archives of Internal Medicine estimates that 21 percent of commonly used drugs are prescribed for off-label uses. More

FDA reviewers: Diabetes drug may pose heart risk
The Associated Press via USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Johnson & Johnson's experimental diabetes drug might bring minor heart risks because it raised cholesterol levels in patient testing, according to federal drug reviewers. In documents released, Food and Drug Administration staff experts conclude studies showed J&J's canagliflozin raised levels of LDL, or bad cholesterol, and slightly increased risk of heart attack, stroke or death, compared to two other types of diabetes medications. More

"Symptoms of gout include sudden, severe attacks of pain, redness and tenderness in joints, often the joint at the base of the big toe, according to the Mayo Clinic."


Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 3, 2012
Dec, 27, 2012
Dec. 20, 2012
Dec. 13, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063